The role of comprehensive genomic profiling for therapeutic decision-making is established in high-risk pediatric cancers, but its utility in rare and diagnostically challenging tumors is unclear. Here we report 123 non-high-risk patients enrolled in the Australian ZERO Childhood Cancer Program for diagnostic uncertain...
David S. Ziegler, A. Sullivan, Dong-Anh Khuong-Quang et al.· Research Square· 0 citations
Neuroblastoma (NB) is the most common extra-cranial solid tumor in children and accounts for approximately 10% of pediatric cancer deaths. Next-generation sequencing studies of patients with high-risk NB identified multiple pathogenic/likely pathogenic (P/LP) germline and oncogenic somatic variants in the Checkpo...
Xue-Ting Xiong, Meagan Beffort, L. Kee et al.· Cancer Research· 0 citations
Introduction Cancer is the most common cause of disease-related mortality in children, highlighting the urgent need for improved care in this population. It is estimated that >15% of children diagnosed with cancer harbour a germline pathogenic variant in a cancer predisposition gene which confers an increased risk to d...
Melissa R Perrino, Suzanne P. MacFarland, Luke D. Maese et al.· BMJ Open· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.